SCHEMBL9106560

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9109657	0.90	PLA2G7 (0.42)	PLA2G7
	SCHEMBL9106802	0.90	PLA2G7 (0.40)	PLA2G7CYP3A4
	SCHEMBL9889664	0.89	PLA2G7 (0.39)	PLA2G7
	SCHEMBL9106542	0.88	PLA2G7 (0.41)	PLA2G7CYP3A4
	SCHEMBL9889672	0.87	PLA2G7 (0.37)	PLA2G7
	SCHEMBL9889679	0.86	PLA2G7 (0.49)	PLA2G7
	SCHEMBL9108319	0.85	PLA2G7 (0.42)	PLA2G7CYP3A4
	SCHEMBL15278069	0.85	PLA2G7 (0.42)	PLA2G7CYP3A4
	SCHEMBL9105792	0.85	PLA2G7 (0.39)	PLA2G7CYP3A4
	SCHEMBL9892545	0.84	CYP3A4 (0.41)	PLA2G7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.